Daily news email for May 08, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
Sartorius Stedim Biotech and c-LEcta Sign Sales Agreement

Mucosis Announces Publication of Preclinical Data Demonstrating Superior Protection by ...

LifeCodexx Successfully Completes Clinical Validation of its Noninvasive Prenatal Test Method ...

Sartorius Stedim Biotech Launches Initiative to Enhance Supply Chain Security

Cellon Launches PharmaTainer(TM) Single-Use Ultra-clean Containers

BioSpace
Having a "Purpose in Life" May Help Shield You From Dementia, Rush University Medical Center Study

Sunscreen Ingredient May Increase Skin Cancer Risk, Study

Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement With Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote

Santen Pharmaceutical Nabs Japanese Co-Promotion Rights to Bayer HealthCare and Regeneron Pharmaceuticals, Inc.'s Eylea

Novartis AG: Pasireotide Works Well in Phase III Acromegaly Trial

BioSpace - Breaking News
Ardea Biosciences, Inc. Announces First Quarter 2012 Financial Results

Health Canada Grants Apricus Biosciences Pre-NDS Meeting for Femprox for Female Sexual Arousal Disorder

Talon Therapeutics, Inc. Receives Notification of Three Month PDUFA Date Extension for Marqibo(R)

pSivida Corp Announces United Kingdom Grants ILUVIEN Marketing Authorization for the Treatment of Chronic Diabetic Macular Edema

Biolex Therapeutics Sells LEX System to and Initiates Sale of Locteron(R)

Biotech News - Business Wire
Fluidigm and the Broad Institute Establish Single-Cell Genomics Research Center

Vascular Closure Systems, Inc. Announces Conclusion of Phase I of the First in Human (FIH) Use of the FastSeal® Bioabsorbable Vascular Access Closure System

Oncology Expert George Demetri, M.D., Joins Blueprint Medicines as a Clinical Advisor

David Allan Lauded for Leadership Biotechnology Leader Named to Industry Award

St. Jude Medical Announces FDA Approval of Assura Implantable Defibrillators with Features That Reduce Inappropriate Shocks

Biotech News - PR Newswire
Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS) - The USB Port to the Brain

HealthEd Taps Kelemen to Lead West Coast Expansion

Phalanx Biotech Group Announces CytoOneArray®, a Targeted Chromosomal Microarray

Free Disaster Preparedness Online Training Course

Instrumentation Laboratory Moves To Direct Distribution Of Hemostasis Product Line In North America

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
VCs See Sharp Drop in Biotech Investment

Investor Groups to Help Laid-Off Merck KGaA Employees Form Spin-offs

NIH Seeks to Find Uses for Shelved Compounds

Piecing Together the Proteome

Friction for Pharma Abroad, But Progress Too

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
Dainippon Sumitomo Pharma annonce que Latuda® (chlorhydrate de lurasidone) a satisfait aux critères principaux et secondaires dans les deux essais cliniques de phases 3 sur la dépression bipolaire I

Innovators in Pediatric Cancer to Share Progress on Ground-Breaking Personalized Medicine Clinical Trial

ClearTrial Awarded Best of Show at Bio-IT World Conference & Expo 2012

RaySearch Laboratories: RaySearch Enters Distribution Agreement for the Spanish Market

Acucela Announces New Data from Its Phase 2a Trial of ACU-4429 in Patients with Advanced Dry AMD/Geographic Atrophy

Clinical Trials - PR Newswire
Non-Drug Depression Treatment Rapidly and Significantly Improves Disease Symptoms and Quality of Life

Children's National Medical Center Breaks MRI Speed Sound Barrier

Physician-Patient Alliance for Health & Safety: Monitoring Technology for PCA Pumps Can Prevent Adverse Events: So Why Are Hospitals Not Using It

New Report Finds Americans Are Unprepared To Face A Disability, Risking Financial Futures

Sports-Related Concussions Topic of June Brain Health Conference

CNN Top Stories
Opinion: 401(k)s are too risky

Underwear, printers and al Qaeda

Europe voters revolt against cuts

'Where the Wild Things Are' author dies

Investigators study bomb device

Contract Pharma
Bayer, Regeneron, Santen in EYLEA Promotion Pact

Abbott Settles Depakote Allegations

Theorem Clinical Research Names Asia-Pac Director

Marina Biotech, Monsanto in Exclusive Licensing Pact

Algorithme Expands Bioanalytical Offering

FDA Drugs- What's New
FDA Drug Safety Communication: Safety review update of cancer drug Revlimid (lenalidomide) and risk of developing new types of malignancies

Comunicado de la FDA sobre la seguridad de los medicamentos: Información actualizada sobre la interacción entre el medicamento Victrelis (boceprevir) y ciertos medicamentos reforzados inhibidores de la proteasa del VIH

Comunicado de la FDA sobre la seguridad de los medicamentos: Información actualizada sobre la interacción entre el medicamento Victrelis (boceprevir) y ciertos medicamentos reforzados inhibidores de la proteasa del VIH

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva advertencia y contraindicación sobre medicamentos para la presión arterial que contienen aliskiren

Comunicado de la FDA sobre la seguridad de los medicamentos: Nueva advertencia y contraindicación sobre medicamentos para la presión arterial que contienen aliskiren

FDA News - Business Wire
SANUWAVE Receives Conditional Approval from the FDA on Clinical Trial Plan for dermaPACE

Rexahn Pharmaceuticals Submits Archexin Phase II Protocol for Ovarian Cancer to FDA

GTx Announces Removal of Full Clinical Hold By FDA for Capesaris® In Advanced Prostate Cancer

Resumen: Clinigen obtiene la aprobación de la FDA de Estados Unidos para Foscavir, un tratamiento del herpes y de las infecciones por citomegalovirus relacionadas con el VIH/SIDA

Samenvatting: Clinigen krijgt goedkeuring van Amerikaanse FDA voor Foscavir voor HIV/AIDS-gerelateerde cytomegalovirus infecties en herpes

FDA Press Releases
FDA issues final rule on sterility testing of biological products

FDA permits marketing of a new device for abdominal surgery

FDA approves new orphan drug to treat a form of Gaucher disease

FDA approves new antibacterial treatment for plague

FDA challenges marketing of DMAA products for lack of safety evidence

FDA Vaccines, Blood and Biologics - What's New
Moon Marine USA Corporation voluntarily recalls frozen raw yellowfin tuna product Nakaochi Scrape associated with a multistate outbreak of Salmonella Bareilly infections

Multi-Center Fellowship in Regenerative Medicine

FDA Webinar on Safety of the Blood Supply

WinRho SDF Liquid

Flebogamma DIF 5%

FierceBiotech
FDA withdraws hold on GTx's prostate cancer drug

UPDATED: Arena shares up after FDA briefing on lorcaserin

Ex-Sanofi chemist locked up after theft

Arena shares up after FDA briefing on lorcaserin

Talon sinks after FDA prolongs cancer drug review

FierceBiotech IT
Investors pour $50.8M into genomics standout Oxford Nanopore

Software provider to Merck taps IBM cloud to fight fake drugs

Startup tries Apple-like strategy in genomics field

A case for 'open source' clinical trial data (locked behind a pay wall)

Genomics tops chart of social media buzz in biotech IT

FierceBiotech Research
Researchers find key to premature aging syndrome

Honeybee substance freezes prostate cancer growth (Hint, it's not honey)

Controversial bird flu study details revealed

Stem cells grown from skin treat muscular dystrophy in mice

University of Miami gains $10M to expand stem cell R&D

FiercePharma
Activist investor presses Par Pharma to sell itself

Docs riled by FDA's proposal to open up drug access

Sanofi plant starts shutdown with 112 layoffs

Europe may be austere, but it's also hiring in pharma

Novartis may weigh Lucentis price cut in U.K.

FiercePharma Manufacturing
BASF erecting 50,000-ton-plus formic acid plant in Louisiana

Drug manufacturing problems bad for business but good for jobs

Baxter bitten again by problems with Colleague infusion pumps

Pfizer to grow manufacturing capacity in Indonesia

Sanofi closing plant in Missouri, 4 years later than expected

FierceVaccines
Ampligen-FluMist nasal trial begins

'Designer' lymph nodes could boost cancer vaccines

Japan OKs Sanofi's inactivated polio vaccine

GSK's Nimenrix gets green light in Europe

Mucosis nasal flu vaccine shows positive results in animals

Health News - BizJournals.com
Florida to receive $5M from Abbott Laboratories settlement

Monsanto enters licensing deal with Marina Biotech

GTx loses in first quarter, revenue falls 80 percent

Annual Facebook Rankings: Which Minnesota companies are most "liked"

Overland Park approves $65M in bonds to attract Teva

Health News - CNBC
Nebraska to get nearly $5M in Abbott settlements

Home Health Care Is One of the Most Profitable Franchises

Idaho getting $1.2 million in Abbott settlement

FDA favors first drug for HIV prevention

Utah receiving $4 million in drug settlement

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

Inside Industry - Gen
mAb Therapeutics for Alzheimer Disease Unlikely to Be Fully Successful, According to GEN Poll

Eleven Increases Series A Fundraising to $45M for Protein Therapeutics Pipeline

Investors Remain Cool to Dendreon after Q1 Results

Eleven Increses Series A Fundraising to $45M for Protein Therapeutics Pipeline

Sutro Adds $16.5M to Series C Financing to Further Antibody Platforms

Marketwire - Pharma and Biotech
Novo Energies Corporation Announces New Name Change to Immunovative, Inc. and New Trading Symbol "IMUN"

BIOTRONIK prnte les premiers DAI, D-TRC et S-TRC au monde dotde la technologie ProMRI(R) 'occasion d'Heart Rhythm 2012

Triton Pacific Capital Partners Funds Institutional Pharmacy Platform Company

BIOTRONIK presenta i primi dispositivi ICD, CRT-D e CRT-P al mondo con tecnologia ProMRI(R) alla conferenza Heart Rhythm 2012

EXTEDO Adds Submission Consulting Group to Network of Global Partners

MassBio News
10 reasons to attend the BIO International Convention

New Therapy Helps Patients Soar to New Heights

BIO 2012 Massachusetts Pavillion Patient Profiles

By Popular Demand: New Professional Development Courses Aim to Meet Industry Needs

10 reasons to attend bio international convention

Medical Pharma - PR Newswire
Psychemedics Corporation Announces Record First Quarter Revenues

UV Protection Critical for Eye Health

Access Legal from Shoosmiths Announces £10.8m Payout for 11-year-old Left Disabled From Birth

eCardio's CEO to Speak During "Act at the Speed of Opportunity" Event Presented by Comcast Business Class and Inc.

New Milestones In Visius Surgical Theatre By Imris

National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

Nature Biotechnology
High-efficiency TALEN-based gene editing produces disease-resistant rice

Recasting natural product research

A work in progress

Drug pipeline: 1Q12

Biotech equities heat up in 1Q12

New York Times- Biotechnology
DEALBOOK; Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

White House Promotes a Bioeconomy

George Rathmann, Chief of Amgen, Dies at 84

Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances

Cancer Center, in Suit, Claims Ex-Official Took Research

New York Times- Pharmaceuticals
Vertex’s Cystic Fibrosis Therapy Is Called ‘Game-Changing’

F.D.A. Staff Raises Concerns About Arthritis Drug

Abbott to Pay $1.6 Billion Over Illegal Marketing

Warnings on Drug Labels

A Rare Form of Dementia Tests a Vow of ‘for Better, for Worse’

OnBioVC
ImmuneXcite, Inc.: Series A $2.4M

AirXpanders, Inc.: Series D $10.3M

MC10, Inc.: Series B $2M

CN Creative, Ltd.: Series A $3.1M

SEA Medical Systems, Inc.: Series B $3M

Outsourcing-Pharma
SGS adds formulation development services and expands US lab

Once a friend now an enemy: Over zealous EU regulators could hamper the CMO market, says analyst

Pharmas must give patients voice says DIA Europe director

Improve patient compliance by designing trials around real life, says expert

People special: social media gets job hunters noticed

Pharma News - Business Wire
Research and Markets: Pharmaceuticals - North America (NAFTA) Industry Guide

Covidien

Research and Markets: Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2012

Research and Markets: Astrocytoma - Pipeline Review, H1 2012

Data Affirms Long Term Benefit of Adding L-methylfolate To Antidepressants

Pharma News - PharmiWeb
ACEP Announces 39th Annual National EMS Week, May 20-26 With the Theme "EMS: More than a Job, a Calling"

Coming to Your City: The 3in4 Need More Bus Hits the Road With National Senior Talent Search & Awareness Tour

Virginia Women's Center Makes Generous Donation and Commitment in Hanover County

SpineGuard Expands U.S. Sales Organization and Creates Four Areas to Support Growing Number of Independent Distributors Marketing Its PediGuard® Product Family

Customers celebrate the launch of Tecan Australia

Pharma News - PR Newswire
PDR and the iHealth Alliance Announce New Drug Safety Certification for EHRs

Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012

Life Extension Foundation® study finds Cognitex® with NeuroProtection Complex may provide a positive impact on cognitive performance

Roskamp Institute Reports Beneficial Effects of Nutritional Supplementation with Anatabine in an Animal Model of Multiple Sclerosis

AMCC Launches First In the Nation Prescription Drug Prevention Mobile App

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

PRWeb - Biotechnology
invivodata Performing Novel ClinRO Migration Services for UCB Pharma

Number One Technothriller of 2011 Discounted to 99 Cents Upon Launch...

Business, Clinical Research Successes Lead to Executive Transition at...

Parabel, Inc. and CECEP - Chongqing Industry Co., Ltd. Sign Master...

Matakina and Breast Cancer Screening Programme of the French Community...

PRWeb - Pharmaceuticals
Indian Pharmaceutical Market Analyzed & Forecast in New Topical...

DIA Japan Cardiac Safety Workshop Ushers in New Age of Drug Approval

DermLaser Institute of Dallas, Now Offering The Latest Photodynamic...

Healthcare Solutions Announces All-Product Contract with BrickStreet...

Boomerang Reusable Temperature Recorder is Designed to Help...

Scientific American
Brain Scans Reveal Dogs' Thoughts

Giant Flealike Pest Put the Bite on Dinosaurs

Triple Crown-Bound Horse Breeders Start to Look to Genetics

Giant Flea-Like Pest Put the Bite on Dinosaurs

Stonehenge Had Lecture Hall Acoustics

Sports - ESPN Basketball
Illinois State hires Vandy asst. Muller as coach

Source: Vandy's Muller will be Illinois St. coach

Ex-Iowa St. forward Godfrey transfers to LSU

Richard Pitino's contract with FIU for six years

UConn assuming Calhoun will return for '12-13

Sports News - ESPN
So. Miss RB Woodyard arrested after robbery

Report: Texas A&M AD Byrne plans to retire

Three Longhorns players arrested outside club

Sandusky shower allegations adjusted to 2001

Purdue's leading WR Edison arrested for felony

Xconomy Life Sciences
San Diego's Celladon Extends Round to $53M, Opens European Office

Sutro Biopharma Pulls in $16M for New Antibody Drugs

Eleven Biotherapeutics Raises $20M to Advance Dry-Eye Drug

First Comes The $1,000 genome, Then Comes The $10,000 Analysis

Dendreon Meets Expectations with $82M in 1st Quarter Provenge Sales

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)